The Impact of COVID-19 on Solid Organ Donation: The North Italy Transplant Program Experience.


Journal

Transplantation proceedings
ISSN: 1873-2623
Titre abrégé: Transplant Proc
Pays: United States
ID NLM: 0243532

Informations de publication

Date de publication:
Nov 2020
Historique:
received: 11 06 2020
revised: 17 06 2020
accepted: 17 06 2020
pubmed: 28 7 2020
medline: 11 11 2020
entrez: 26 7 2020
Statut: ppublish

Résumé

The coronavirus disease 2019 (COVID-19) outbreak has unfavorably influenced solid organ donation activity. The aim of this study is to investigate the effect of COVID-19 on transplantation in the North Italy Transplant program (NITp). This cross-sectional study included all consecutive potential deceased donors proposed in the NITp in 6 weeks after February 21, 2020 (period A) compared to all potential donors during the same time frame of the previous years (period B) and all potential donors 6 weeks before February 20, 2020 (period C). Fifty-eight deceased donors were proposed during period A, 95 were proposed during period B, and 128 were proposed during period C. After the evaluation process, 32 of 58 (55.2%), 60 of 95 (63.2%), and 79 of 128 (61.7%) donors were used for organ donation in periods A, B, and C, respectively (P value = .595). We observed a 47% donation reduction in period A compared to period B and a 60% reduction compared to period C. There was a reduction of 44% and 59% in transplantation comparing period A with period B and period C, respectively. This study showed an important reduction of donations and transplants during the COVID-19 pandemic.

Sections du résumé

BACKGROUND BACKGROUND
The coronavirus disease 2019 (COVID-19) outbreak has unfavorably influenced solid organ donation activity.
AIM OBJECTIVE
The aim of this study is to investigate the effect of COVID-19 on transplantation in the North Italy Transplant program (NITp).
MATERIAL AND METHODS METHODS
This cross-sectional study included all consecutive potential deceased donors proposed in the NITp in 6 weeks after February 21, 2020 (period A) compared to all potential donors during the same time frame of the previous years (period B) and all potential donors 6 weeks before February 20, 2020 (period C).
RESULTS RESULTS
Fifty-eight deceased donors were proposed during period A, 95 were proposed during period B, and 128 were proposed during period C. After the evaluation process, 32 of 58 (55.2%), 60 of 95 (63.2%), and 79 of 128 (61.7%) donors were used for organ donation in periods A, B, and C, respectively (P value = .595). We observed a 47% donation reduction in period A compared to period B and a 60% reduction compared to period C. There was a reduction of 44% and 59% in transplantation comparing period A with period B and period C, respectively.
CONCLUSIONS CONCLUSIONS
This study showed an important reduction of donations and transplants during the COVID-19 pandemic.

Identifiants

pubmed: 32709414
pii: S0041-1345(20)32589-6
doi: 10.1016/j.transproceed.2020.06.025
pmc: PMC7316055
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2578-2583

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Références

JAMA. 2020 Apr 28;323(16):1574-1581
pubmed: 32250385
Clin Gastroenterol Hepatol. 2020 Aug;18(9):2131-2133.e1
pubmed: 32334081
Am J Transplant. 2020 Jul;20(7):1780-1784
pubmed: 32243677
N Engl J Med. 2020 May 7;382(19):1869
pubmed: 32220200
Kidney Int. 2020 Jun;97(6):1083-1088
pubmed: 32354634
Kidney Int Rep. 2020 Apr 04;5(5):580-585
pubmed: 32292866
Transpl Int. 2020 Aug;33(8):969-970
pubmed: 32348586

Auteurs

Antonino Cannavò (A)

Unità Operativa Complessa (UOC) Coordinamento Trapianti, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ca' Granda-Ospedale Maggiore Policlinico, Milan, Italy. Electronic address: antonino.cannavo@policlinico.mi.it.

Serena Maria Passamonti (SM)

Unità Operativa Complessa (UOC) Coordinamento Trapianti, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ca' Granda-Ospedale Maggiore Policlinico, Milan, Italy.

Daniela Martinuzzi (D)

Unità Operativa Complessa (UOC) Coordinamento Trapianti, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ca' Granda-Ospedale Maggiore Policlinico, Milan, Italy.

Antonio Longobardi (A)

Unità Operativa Complessa (UOC) Coordinamento Trapianti, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ca' Granda-Ospedale Maggiore Policlinico, Milan, Italy.

Andrea Fiorattini (A)

Unità Operativa Complessa (UOC) Coordinamento Trapianti, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ca' Granda-Ospedale Maggiore Policlinico, Milan, Italy.

Nicoletta Margherita Troni (NM)

Unità Operativa Complessa (UOC) Coordinamento Trapianti, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ca' Granda-Ospedale Maggiore Policlinico, Milan, Italy.

Martha Helena Esposito (MH)

Unità Operativa Complessa (UOC) Coordinamento Trapianti, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ca' Granda-Ospedale Maggiore Policlinico, Milan, Italy.

Nicolina Dell'orefice (N)

Unità Operativa Complessa (UOC) Coordinamento Trapianti, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ca' Granda-Ospedale Maggiore Policlinico, Milan, Italy.

Rosanna Torelli (R)

Unità Operativa Complessa (UOC) Coordinamento Trapianti, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ca' Granda-Ospedale Maggiore Policlinico, Milan, Italy.

Tullia Maria De Feo (TM)

Unità Operativa Complessa (UOC) Coordinamento Trapianti, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ca' Granda-Ospedale Maggiore Policlinico, Milan, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH